首页> 美国卫生研究院文献>Toxicological Sciences >Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line
【2h】

Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line

机译:使用永生人类肝细胞系构建的3D球体确定药物毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Numerous publications have documented that the immortal cells grown in three-dimensional (3D) cultures possess physiological behavior, which is more reminiscent of their parental organ than when the same cells are cultivated using classical two-dimensional (2D) culture techniques. The goal of this study was to investigate whether this observation could be extended to the determination of LD50 values and whether 3D data could be correlated to in vivo observations. We developed a noninvasive means to estimate the amount of protein present in a 3D spheroid from it is planar area (± 21%) so that a precise dose can be provided in a manner similar to in vivo studies. This avoided correction of the actual dose given based on a protein determination after treatment (when some cells may have lysed). Conversion of published in vitro LC50 data (mM) for six common drugs (acetaminophen, amiodarone, diclofenac, metformin, phenformin, and valproic acid) to LD50 data (mg compound/mg cellular protein) showed that the variation in LD50 values was generally less than that suggested by the original LC50 data. Toxicological analysis of these six compounds in 3D spheroid culture (either published or presented here) demonstrated similar LD50 values. Although in vitro 2D HepG2 data showed a poor correlation, the primary hepatocyte and 3D spheroid data resulted in a much higher degree of correlation with in vivo lethal blood plasma levels. These results corroborate that 3D hepatocyte cultures are significantly different from 2D cultures and are more representative of the liver in vivo.
机译:许多出版物已经证明,在三维(3D)培养中生长的永生细胞具有生理行为,这比使用经典的二维(2D)培养技术培养相同细胞时更令人联想到其亲代器官。这项研究的目的是调查这种观察是否可以扩展到LD50值的确定以及3D数据是否可以与体内观察相关。我们开发了一种非侵入性方法,可以从平面区域(±21%)估算3D球体中存在的蛋白质量,以便可以以类似于体内研究的方式提供精确剂量。这样就避免了在治疗后(某些细胞可能已经裂解时)基于蛋白质测定得出的实际剂量校正。将六种常用药物(对乙酰氨基酚,胺碘酮,双氯芬酸,二甲双胍,苯乙双胍和丙戊酸)的已公开体外LC50数据(mM)转换为LD50数据(mg化合物/ mg细胞蛋白)表明LD50值的变化通常较小比原始LC50数据所建议的要高。在3D球形培养物中对这6种化合物的毒理学分析(无论是在此处发表还是在此处展示)均显示出相似的LD50值。尽管体外2D HepG2数据显示出很差的相关性,但原代肝细胞和3D球体数据导致与体内致死血浆水平的相关性更高。这些结果证实了3D肝细胞培养物与2D培养物显着不同,并且更能代表体内肝脏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号